PubRank

C Bernasconi

Author PubWeight™ 100.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 1997 5.09
2 Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet 1993 4.96
3 The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 1997 3.28
4 A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness. J Clin Microbiol 1995 3.20
5 Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood 2000 3.07
6 Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. J Clin Microbiol 1997 2.24
7 Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation. Am J Transplant 2009 1.88
8 Prospective age-matching in elderly kidney transplant recipients--a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2007 1.72
9 The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study. Haematologica 1998 1.66
10 The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patients. Br J Haematol 1980 1.63
11 Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity. Cancer 1998 1.58
12 Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood 1997 1.53
13 Evaluation of the relatedness of strains of Mycobacterium avium using pulsed-field gel electrophoresis. Eur J Clin Microbiol Infect Dis 1995 1.51
14 Genotypic characterization of Mycobacterium avium strains recovered from animals and their comparison to human strains. Appl Environ Microbiol 1995 1.47
15 Emergence of canine ocular Thelaziosis caused by Thelazia callipaeda in southern Switzerland. Vet Parasitol 2008 1.28
16 Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999 1.09
17 Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol 1997 1.05
18 Extramedullary disease in Ph'-positive chronic myelogenous leukemia: frequency, clinical features and prognostic significance. Haematologica 1990 1.04
19 The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement. Haematologica 1998 1.03
20 Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul 1991 1.03
21 Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women. Epilepsia 1999 1.02
22 A major oligomeric fibroblast proteoglycan identified as a novel large form of type-XII collagen. Eur J Biochem 1992 0.98
23 Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†). Am J Transplant 2013 0.96
24 Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies. Bone Marrow Transplant 2000 0.94
25 Translocation (8;16) in a patient with acute myelomonocytic leukemia, occurring after treatment with fludarabine for a low-grade non-Hodgkin's lymphoma. Haematologica 2000 0.94
26 Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients. Leukemia 2003 0.93
27 The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders. Br J Haematol 1999 0.93
28 A single heparin binding region within the fibrinogen-like domain is functional in chick tenascin-C. J Biol Chem 1995 0.93
29 Chronic myelomonocytic leukemia: clinical features, cytogenetics, and prognosis in 30 consecutive cases. Hematol Oncol 1985 0.93
30 Clinicopathologic and immunologic characteristics of non-Hodgkin's lymphomas presenting in the orbit. A report of eight cases. Cancer 1985 0.92
31 Plasma cell leukemia: a report on 15 patients. Eur J Haematol Suppl 1989 0.88
32 Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation. Bone Marrow Transplant 1998 0.88
33 Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution. Leukemia 2005 0.88
34 Photochemical inactivation of single-stranded viral DNA in the presence of urocanic acid. Photochem Photobiol 1983 0.88
35 Pathogenetic significance of "pure" monosomy 7 in myeloproliferative disorders. Analysis of 14 cases. Hum Genet 1982 0.88
36 Treatment-related leukemia in Hodgkin's disease: a multi-institution study on 75 cases. Hematol Oncol 1987 0.87
37 Isolation of Reed-Sternberg cells from lymph nodes of Hodgkin's disease patients. Blood 1989 0.86
38 Plateau phase in multiple myeloma: an end-point of conventional-dose chemotherapy. Haematologica 1999 0.86
39 Spontaneous splenic rupture during induction chemotherapy for acute promyelocytic leukemia successfully treated with splenectomy. Haematologica 1990 0.86
40 p230 does not always predict a mild clinical course in myeloid malignancies: e19a2 bcr/abl fusion transcript with additional chromosome abnormalities in a patient with acute monoblastic leukemia (M5a). Haematologica 2001 0.85
41 Use of V-Y flap for vulvar reconstruction. Gynecol Oncol 1996 0.84
42 The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma refractory to chemotherapy. Int J Clin Lab Res 1998 0.84
43 Multiple myeloma in younger patients: the role of age as prognostic factor. Ann Hematol 1998 0.84
44 Primary mediastinal B-cell lymphoma: update of its clinicopathologic features. Leuk Lymphoma 1997 0.83
45 Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma. Ann Oncol 1999 0.83
46 Thrombotic events are not exclusive to the remission induction period in patients with acute lymphoblastic leukemia: a report of two cases of cerebral sinus thrombosis. Ann Hematol 1997 0.82
47 Efficacy of pipobroman in the treatment of polycythemia vera: long-term results in 163 patients. Haematologica 2000 0.82
48 Organisation of the tmb catabolic operons of Pseudomonas putida TMB and evolutionary relationship with the xyl operons of the TOL plasmid pWW0. Gene 1996 0.81
49 Blood stem cell collections in multiple myeloma: definition of a scoring system. Bone Marrow Transplant 2000 0.81
50 Acute myeloid leukemia and diabetes insipidus: results in 5 patients. Acta Haematol 1995 0.81
51 A new mumps virus lineage found in the 1995 mumps outbreak in western Switzerland identified by nucleotide sequence analysis of the SH gene. Arch Virol 1996 0.81
52 Immunohistochemical detection of porcine epidemic diarrhea virus compared to other methods. Clin Diagn Lab Immunol 1998 0.80
53 Norfloxacin versus cotrimoxazole for infection prophylaxis in granulocytopenic patients with acute leukemia. A prospective randomized study. Haematologica 1990 0.80
54 Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea. Leukemia 2002 0.80
55 A wavelength effect on urocanic acid E/Z photoisomerization. Photochem Photobiol 1984 0.79
56 VP 16-213 and cytosine-arabinoside combination chemotherapy for refractory acute lymphoblastic leukemia in adults. Eur J Cancer Clin Oncol 1984 0.79
57 Age determines vascular reactivity as measured by optical rhinometry. Eur J Clin Invest 2009 0.79
58 Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence. Leuk Lymphoma 1997 0.79
59 Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity. Haematologica 2000 0.79
60 Hemodynamics and renal function during low frequency positive pressure ventilation with extracorporeal CO2 removal. A comparison with continuous positive pressure ventilation. Intensive Care Med 1980 0.78
61 CHOP versus CNOP (N = mitoxantrone) in non-Hodgkin's lymphoma: an interim report comparing efficacy and toxicity. Haematologica 1988 0.78
62 Mitoxantrone and etoposide: an effective regimen for refractory or relapsed acute myelogenous leukemia. Eur J Haematol 1989 0.78
63 A successful combination of plasma exchange and intravenous cyclophosphamide in a patient with a refractory thrombotic thrombocytopenic purpura. Eur J Haematol 1999 0.78
64 Secondary lymphomas: a review on lymphoproliferative diseases arising in immunocompromised hosts: prevalence, clinical features and pathogenetic mechanisms. Haematologica 1990 0.78
65 Multiple granulocytic sarcoma during complete hematologic remission of acute nonlymphoid leukemia. Acta Haematol 1989 0.78
66 Management of acute promyelocytic leukemia relapse in the ATRA era. Haematologica 1998 0.78
67 Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patients. Eur J Cancer Clin Oncol 1982 0.78
68 Characterization of AIDS-associated tumors in Italy: report of 435 cases of an IVDA-based series. Cancer Detect Prev 1990 0.78
69 Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA. Eur J Haematol 1990 0.78
70 Adult leukemia developing after aplastic anemia: report of 8 cases. Acta Haematol 1988 0.78
71 Assessment of renal function in patients with multiple myeloma: the role of urinary proteins. Ann Hematol 1999 0.77
72 Myelofibrosis in chronic granulocytic leukaemia: clinicopathologic correlations and prognostic significance. Br J Haematol 1986 0.77
73 Chronic myelogenous leukemia and exposure to ionizing radiation--a retrospective study of 443 patients. Ann Hematol 1995 0.77
74 Efficacy trial of pipobroman in polycythemia vera and incidence of acute leukemia. J Clin Oncol 1984 0.77
75 Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999 0.77
76 Hemoglobin oxygen affinty in patients with low-output heart failure and cardiogenic shock after acute myocardial infaraction. Eur J Cardiol 1975 0.77
77 Trisomy 11 and a complex t(11;11;22) in a patient with acute myelomonocytic leukemia (AML-M4) following myelodysplasia (MDS): a cytogenetic study of a mechanism of leukemogenesis. Cancer Genet Cytogenet 2000 0.77
78 Effects of infusions of ACTH in the chronically catheterized pregnant ewe and her fetus. Am J Physiol 1998 0.77
79 Transposition of 9q34 and 22 (q11toqter) regions has a specific role in chronic myelocytic leukemia. Hum Genet 1979 0.77
80 Acute leukemia occurring in a primary neoplasia (secondary leukemia). A Review of biological, epidemiological and clinical aspects. Haematologica 1986 0.77
81 The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia. Clinical results in 46 patients. Cancer 1993 0.77
82 Effects of ACTH-induced hypertension in the pregnant ewe. J Cardiovasc Pharmacol 1999 0.77
83 Impact of advanced age on the management of acute nonlymphocytic leukemia: a study of 103 patients. Acta Haematol 1990 0.77
84 Transient response of myeloma clone to pamidronate therapy. Haematologica 1999 0.77
85 Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia. Blood 1982 0.76
86 Clinical relevance of terminal transferase and adenosine deaminase in leukemia. Adv Exp Med Biol 1982 0.76
87 Levels of soluble low affinity IL2 receptors (s-IL2 R) and TNF in the serum after BMT. Bone Marrow Transplant 1991 0.76
88 A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4) Leukemia 1999 0.75
89 The optimal MMF dose in tacrolimus treated patients. Am J Transplant 2014 0.75
90 Human lymphoblastoid interferon for hairy cell leukemia: results from the Italian Cooperative Group. Leukemia 1987 0.75
91 Adult Ki-1-positive large cell anaplastic lymphoma presenting with skin lesions. Acta Haematol 1989 0.75
92 Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma. J Clin Oncol 1986 0.75
93 Prompt response to high-dose intravenous immunoglobulins given as first-line therapy in post-transplant thrombotic thrombocytopenic purpura. Bone Marrow Transplant 2000 0.75
94 Bone marrow T-cell subsets in patients with monoclonal gammopathies: correlation with clinical stage and disease status. Haematologica 1997 0.75
95 [Myelodysplastic syndromes: multiplicity of the hematologic and clinical aspects]. Haematologica 1989 0.75
96 Therapy of essential thrombocythemia with alpha-interferon: results and prospects. Eur J Haematol Suppl 1990 0.75
97 Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma. Haematologica 1998 0.75
98 Therapy-related myelodysplastic syndromes and acute leukemias. Leukemia 1992 0.75
99 Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. Ann Hematol 2001 0.75
100 Cryopreservation of marrow cells for ABMT. Is there any effect on the harvested leukaemic cells? Bone Marrow Transplant 1989 0.75
101 Efficacy of a combination of idarubicin, etoposide and intermediate-dose cytosine arabinoside as salvage therapy in relapsing or resistant unfavorable lymphoma. Haematologica 1998 0.75
102 [Incidence of mycotic infections in patients with acute myeloid leukemia. Evaluation of the drug sensitivity of the isolated strains]. G Ital Chemioter 1986 0.75
103 [The diagnosis of non-Hodgkin's lymphoma in a patient with Marfan's syndrome]. Minerva Med 1993 0.75
104 [Affinity of hemoglobin for oxygen in uremic patients treated with periodic hemodialysis. Comparison of the pre- and post-dialytic phases]. Minerva Med 1973 0.75
105 [Computerized system for use with extracorporeal oxygenators]. Boll Soc Ital Cardiol 1975 0.75
106 [Clinical and immunological problems in autoimmune hemolytic anemias]. Haematologica 1970 0.75
107 [Latent and manifest folic acid deficiency in hemoglobinopathies. Diagnostic and therapeutic aspects]. Minerva Med 1974 0.75
108 A low serum beta 2-microglobulin level despite bulky tumor is a characteristic feature of primary mediastinal (thymic) large B-cell lymphoma: implications for serologic staging. Eur J Haematol 1996 0.75
109 Responses of fetal sheep to reduced maternal renal blood flow and maternal hypertension. Am J Physiol 1996 0.75
110 DNA immunization of mice against the VP1 capsid protein of coxsackievirus B4. Scand J Immunol 2002 0.75
111 [AIDS: duties of the Transfusion Service and Hematology Clinic]. Riv Emoter Immunoematol 1985 0.75
112 [Anti-infective therapy in acute leukemias]. Minerva Med 1975 0.75
113 Hemorrhagic and thrombotic complications in polycythemia vera. A clinical study. Haematologica 1989 0.75
114 [Carboxyhemoglobinemic levels and cardiovascular diseases]. Cardiol Prat 1975 0.75
115 N-acetylcysteine in the treatment of steroid-resistant acute graft-versus-host-disease: preliminary results. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Transplantation 1999 0.75
116 [Bence-Jones protein and its significance in clinical medicine]. Minerva Med 1972 0.75
117 Mitoxantrone for refractory and relapsed acute leukemia. Cancer 1990 0.75
118 Evidence-based approach to treatment of myelodysplastic syndromes. Haematologica 2001 0.75
119 [Idiopathic thrombocytopenic purpura: therapeutic aspects in the adult]. Haematologica 1991 0.75
120 Monosomy 7 in the blast crisis of Ph 1 positive chronic granulocytic leukaemia (CGL): incidence and clinico-haematological features. Br J Haematol 1987 0.75
121 Monitoring of extracorporeal membrane oxygenation with a PDP 8/e computer. Bull Eur Physiopathol Respir 1977 0.75
122 Therapy-related ovarian dysfunction in women treated for Hodgkin's disease. Haematologica 1986 0.75
123 Efficacy trial of pipobroman in essential thrombocythemia: a study of 24 patients. Cancer Treat Rep 1984 0.75
124 Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy. Ann Oncol 1994 0.75
125 [Hematologic diseases due to immune complexes]. Recenti Prog Med 1975 0.75
126 [Production of antibodies gamma-19S and gamma-7S during the primary and secondary immunologic response. Experimental studies on rats immunized with human erythrocytes]. Riv Emoter Immunoematol 1967 0.75
127 [Comparison of 2 anesthetic protocols in colonoscopy on a series of 100 patients]. Agressologie 1989 0.75
128 [Use of alpha-interferon in the treatment of hairy-cell leukemia]. Haematologica 1991 0.75
129 [Combination of buprenorphine and propofol for the anesthesia of a burnt child]. Ann Fr Anesth Reanim 1992 0.75
130 Cyclosporine in the treatment of aplastic anaemia and pure red-cell aplasia. Bone Marrow Transplant 1989 0.75
131 A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome. Cancer Genet Cytogenet 1998 0.75
132 [Blood viscosity: an original method for the study of low values of the shear rate]. Ric Clin Lab 1985 0.75
133 Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse. Br J Haematol 2000 0.75
134 Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experience. Ann Hematol 2001 0.75
135 In vitro effects of fructose-1,6-diphosphate on oxygen affinity and electrolyte equilibrium in human blood. Res Commun Chem Pathol Pharmacol 1983 0.75
136 [The mode of action of immunosuppressive agents. 3. Study of the phase of the immunological response sensitive to treatment with corticosteroids]. Riv Emoter Immunoematol 1967 0.75
137 The oxyhemoglobin dissociation curve in hypercapnic patients. Am Heart J 1974 0.75
138 Interferon alpha-2b as treatment for Philadelphia-negative chronic myeloproliferative disorders with excessive thrombocytosis. Br J Haematol 1989 0.75
139 [Clinical applications of autologous bone marrow transplants. Introduction to a round table]. Riv Emoter Immunoematol 1985 0.75
140 Low-grade malignancy non-Hodgkin's lymphomas: prognostic relevance of their clinicopathologic heterogeneity. Tumori 1983 0.75
141 [Pathology caused by immune complexes in hematology]. Minerva Med 1975 0.75
142 Trisomy 12 in a case of large cell, immunoblastic, polymorphous non-Hodgkin's lymphoma with IgG kappa monoclonal paraprotein. Cancer Genet Cytogenet 1984 0.75
143 Risk of leukemia in patients treated for Hodgkin's disease. Eur J Cancer Clin Oncol 1982 0.75
144 Hodgkin's disease in association with acquired immunodeficiency syndrome (AIDS). A report on 36 patients. Gruppo Italiano Cooperativo AIDS and Tumori. Acta Oncol 1989 0.75
145 Lymphoblastic lymphoma in adults: a study on 30 patients treated with two different programs according to bone marrow findings. Tumori 1984 0.75
146 [Pathology of immune complexes in hematology]. Riv Emoter Immunoematol 1980 0.75
147 Immunoblastic lymphoma: a clinicopathologic study with emphasis on the cases intervening during or following other disorders. Tumori 1985 0.75
148 Hematologic and clinical features of patients with chromosome 5 monosomy or deletion (5q). Med Pediatr Oncol 1988 0.75
149 A model for analysing the cost of autologous peripheral blood progenitor cell (PBPC) transplantation. Bone Marrow Transplant 1999 0.75
150 [Normocholesteremic generalized cutaneous xanthomatosis planum in a patient with Waldenstroem's macroglobulinemic lymphoreticulosis]. Minerva Dermatol 1967 0.75
151 Urocanic acid photobiology. Photocycloaddition of N,N-dimethylthymine to urocanic acid. Photochem Photobiol 1983 0.75
152 Splenectomy after initial therapy with alpha-IFN in patients with hairy-cell leukemia (HCL): a multi-center study by the Italian Cooperative Group for HCL. Preliminary results. Eur J Haematol Suppl 1990 0.75
153 Immunofluorescent studies of the skin in mixed cryoglobulinaemia and Schönlein-Henoch purpura. Acta Derm Venereol 1976 0.75
154 [The mode of action of immunosuppressive agents. II. Study of the phase of the immunological response sensitive to treatment with azathioprine]. Riv Emoter Immunoematol 1967 0.75
155 [Thrombocythemias (author's transl)]. Haematologica 1979 0.75
156 [Role of alpha-interferon in the therapy of essential thrombocythemia]. Haematologica 1991 0.75
157 Significance of MLC for BMT with serological HLA-identical related and unrelated donors. Bone Marrow Transplant 1993 0.75
158 [The oxygen dissociation curve of hemoglobin in hepatic cirrhosis]. Minerva Med 1973 0.75
159 Residual mediastinal widening following therapy in Hodgkin's disease. Hematol Oncol 1990 0.75
160 [Assessment of clinical competence of medical school graduates in Italy with standardized patients. The opinion of the examinees]. Recenti Prog Med 1998 0.75
161 [Clinical study of the therapeutic use of a thymus extract with antileukopenic action]. Minerva Med 1970 0.75
162 Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? Leukemia 1997 0.75
163 [Transplant of autologous bone marrow: indications and results]. Riv Emoter Immunoematol 1985 0.75
164 HIV-related thrombocytopenic purpura: a study of 24 cases. Haematologica 1989 0.75
165 Non-Hodgkin's lymphoma in the elderly: the impact of advanced age on therapeutic options and clinical results. Haematologica 1992 0.75
166 Philadelphia chromosome and TdT-positive AML. J Clin Oncol 1984 0.75
167 MACOP-B for advanced stage large cell lymphoma (DLCL). More is better? Italian Multiregional Cooperative Study Group (IMCSGL). Leukemia 1991 0.75
168 [Deficiency and toxic factors that can concur to cause or aggravate anemia in the thalassemic patient]. Minerva Med 1978 0.75
169 Clinical and cytologic characteristics of blastic phase in Ph-positive chronic myeloid leukemia treated with alpha-interferon. Leukemia 1996 0.75
170 Etoposide-cytarabine therapy for acute leukemia following myelodysplastic syndromes or secondary to treatment for malignant diseases. Haematologica 1987 0.75
171 Bone marrow transplantation from unrelated donor in myelodysplastic syndromes. Bone Marrow Transplant 1993 0.75
172 Leukemic phase of non-Hodgkin's lymphomas. Hematological features and prognostic significance. Haematologica 1984 0.75
173 [Use of D-penicillamine in the therapy of autoimmune hemopathies with macromolecular antibodies]. Haematologica 1970 0.75
174 Terminal deoxynucleotidyl transferase-positive acute leukemias evolving from a myelodysplastic syndrome. Am J Hematol 1985 0.75
175 Low-dose arabinosyl cytosine in acute leukemia after a myelodysplastic syndrome and in elderly leukemia. Am J Hematol 1985 0.75
176 [Methods for the molecular identification of anti-erythrocyte antibodies]. Haematologica 1970 0.75
177 [Granulocytopenias due to drugs (author's transl)]. Haematologica 1979 0.75
178 Long-term survival in adult acute leukemia. A multicenter study of 56 patients. Haematologica 1982 0.75
179 Treatment with recombinant human erythropoietin (rHuEpo) in a patient with paroxysmal nocturnal haemoglobinuria: evaluation of membrane proteins CD55 and CD59 with cytofluorometric assay. Br J Haematol 1997 0.75
180 Development of a model of combined bone marrow and small bowel transplantation in swine. Transplant Proc 1998 0.75
181 [Granulocyte transfusion in patients with acute myeloid leukemia subjected to induction chemotherapy: prophylaxis or therapy?]. Riv Emoter Immunoematol 1984 0.75
182 [Alpha-interferon and myelodysplastic syndromes]. Haematologica 1991 0.75
183 [Acute monocytic and myelomonocytic leukemias. Incidence and treatment with an epipodophyllotoxin derivative (VP 16.213)]. Recenti Prog Med 1975 0.75
184 Bone marrow histology in patients with hairy cell leukemia (HCL) treated by human lymphoblastoid interferon. Haematologica 1987 0.75
185 Acute nonlymphocytic leukemia: evidence of clonogenic cells in peripheral blood in early complete remission. Acta Haematol 1989 0.75
186 [Influence of CO on transfer of O2 to the tissues]. Boll Soc Ital Cardiol 1975 0.75
187 [Vinblastine-vincristine combination in the therapy of advanced Hodgkin's disease]. Haematologica 1971 0.75
188 [Use of monoclonal antibodies in hematology]. Riv Emoter Immunoematol 1984 0.75
189 Treatment of Ph'-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (Intron A). Cancer Treat Rev 1988 0.75
190 Effects of inhibition of the maternal renin-angiotensin system on maternal and fetal responses to drainage of fetal fluids. Can J Physiol Pharmacol 1996 0.75
191 Treatment of relapsed and refractory acute myeloid leukemia in adults. Bone Marrow Transplant 1989 0.75
192 CAV chemotherapy (CCNU, melphalan, etoposide) as salvage treatment for relapsing or resistant Hodgkin's disease. Haematologica 1991 0.75
193 Human lymphoblastoid interferon as initial therapy in hairy cell leukaemia: a multicentre study in non-splenectomized patients. Italian Cooperative Group for Hairy Cell Leukemia. Br J Haematol 1989 0.75
194 Steatapheresis: a new term for a new obesity surgery. Plast Reconstr Surg 1999 0.75
195 Combination chemotherapy with alternating MOPP-ABVD in advanced Hodgkin's disease. Haematologica 1989 0.75
196 [Antimycotic prophylaxis with oral amphotericin B in patients with acute myeloid leukemia]. Clin Ter 1986 0.75
197 Modulation of all-trans retinoid acid pharmacokinetics in acute promyelocytic leukaemia by prolonged interferon-alpha therapy. Br J Haematol 1995 0.75
198 [Critical evaluation in the clinic of the so-called "nonspecific reactive lymphadenitis"]. Haematologica 1972 0.75
199 Empiric antibiotic association in the management of febrile episodes in patients submitted to bone marrow transplantation. Bone Marrow Transplant 1989 0.75
200 Effect of methylene blue on P50 and 2,3DPG of human blood in vitro. Experientia 1974 0.75
201 [The mode of action of immunosuppressive agents. I. Study of the phase of the immunological response sensitive to treatment with cyclophosphamide]. Riv Emoter Immunoematol 1967 0.75
202 [Hepatitic complications and transfusional support in the remission-induction treatment of acute myeloid leukemia. Clinical study of l22 cases]. Riv Emoter Immunoematol 1985 0.75
203 beta-Casomorphin-immunoreactivity in the brain stem of the human infant. Res Commun Chem Pathol Pharmacol 1993 0.75
204 [Immune thrombocytopenic purpura and pregnancy]. Riv Emoter Immunoematol 1985 0.75
205 [Effect of propranolol on P 50 and on distribution of H+ and K+ in the human blood]. Boll Soc Ital Cardiol 1973 0.75
206 Clinical utility of terminal deoxynucleotidyl transferase and adenosine deaminase determinations in adult leukemia with a lymphoid phenotype. J Clin Oncol 1984 0.75
207 In vitro effects of pentoxifylline on hemoglobin affinity for oxygen and electrolytic equilibrium of human blood. Ric Clin Lab 1984 0.75
208 Growth factors in the therapy of myelodysplasia: biological aspects. Leuk Lymphoma 1997 0.75
209 [Methemoglobinemia; a description of a case of NADH methemoglobulin reductase deficiency]. Minerva Med 1981 0.75
210 Cytogenetic analysis may improve BMT strategies in acute leukaemias. Bone Marrow Transplant 1989 0.75
211 Hydroxyurea and 6-mercaptopurine in the treatment of chronic granulocytic leukemia. Am J Clin Oncol 1986 0.75
212 Nifedipine has no effects on electrolytic equilibrium and hemoglobin oxygen affinity of human blood in vitro. Res Commun Chem Pathol Pharmacol 1984 0.75